Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas
by Fiedler, Walter (Author)
, Cresta, Sara (Author)
, Schulze-Bergkamen, Henning (Author)
, Dosso, Sara De (Author)
, Weidmann, Jens (Author)
, Tessari, Anna (Author)
, Baumeister, Hans (Author)
, Danielczyk, Antje (Author)
, Dietrich, Bruno (Author)
, Goletz, Steffen (Author)
, Zurlo, Alfredo (Author)
, Salzberg, Marc (Author)
, Sessa, Cristiana (Author)
, Gianni, Luca (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource